| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Laura C. Schulz | Q56418755 |
| P2093 | author name string | Danny J Schust | |
| Kathleen A Pennington | |||
| Daniel L Jackson | |||
| Jessica M Schlitt | |||
| P2860 | cites work | Evolution of the mammalian placenta revealed by phylogenetic analysis | Q24541507 |
| Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Régional Aspirine Mère–Enfant study (Part 2) | Q28195962 | ||
| Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data | Q28211057 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies | Q28350804 | ||
| Loss of Cited2 affects trophoblast formation and vascularization of the mouse placenta | Q28506802 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. | Q30433214 | ||
| Caviomorph placentation as a model for trophoblast invasion | Q33301518 | ||
| Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis | Q33334759 | ||
| Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count | Q33360652 | ||
| Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction | Q33392329 | ||
| Increased angiotensin II in the mesometrial triangle of a transgenic rat model of preeclampsia | Q33648619 | ||
| Role of peroxiredoxin III in the pathogenesis of pre-eclampsia as evidenced in mice | Q33716927 | ||
| Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies | Q33725645 | ||
| Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice | Q33770707 | ||
| Chapter 12. Placental remodeling of the uterine vasculature | Q33801683 | ||
| Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies | Q33930498 | ||
| Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice | Q34517776 | ||
| Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model | Q34533751 | ||
| Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies--a review | Q34615441 | ||
| Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia | Q34656275 | ||
| Progesterone and the risk of preterm birth among women with a short cervix | Q34658686 | ||
| Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension | Q34904184 | ||
| Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia | Q35079406 | ||
| Predicting the risk of pre‐eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP‐A and free β‐hCG | Q35084932 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Maternal hypoxia activates endovascular trophoblast cell invasion | Q36494058 | ||
| Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1 | Q36636243 | ||
| Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
| A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice | Q36752126 | ||
| The two stage model of preeclampsia: variations on the theme | Q37187589 | ||
| Regulation of vascular growth and function in the human placenta. | Q37496317 | ||
| Immunology of pre-eclampsia | Q37717752 | ||
| Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. | Q37776132 | ||
| Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management | Q37826830 | ||
| Treatment and control of peri-parturient metabolic diseases: pregnancy toxemia, hypocalcemia, hypomagnesemia | Q37826886 | ||
| Pre-eclampsia: Risk factors and causal models | Q37846984 | ||
| Early prediction and prevention of pre-eclampsia | Q37849971 | ||
| Contemporary prediction of preeclampsia | Q37850959 | ||
| The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis | Q37855094 | ||
| Animal models of preeclampsia; uses and limitations | Q37865890 | ||
| Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis | Q37884885 | ||
| Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia | Q38311843 | ||
| Differential inhibition of prostacyclin production and platelet aggregation by aspirin | Q39579070 | ||
| Spontaneous preeclamptic toxemia of pregnancy in the patas monkey (Erythrocebus patas) | Q39661343 | ||
| Urinary proteomics for prediction of preeclampsia | Q39797354 | ||
| Placental infarction: a sign of pre-eclampsia in a patas monkey (Erythrocebus patas) | Q41240136 | ||
| Pregnancy hypertension and uterine artery Doppler ultrasound | Q41286557 | ||
| Simplified technique to produce toxemia in the rat: considerations on cause of toxemia | Q41629684 | ||
| Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005. | Q43621863 | ||
| Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. | Q44717981 | ||
| Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats | Q44895722 | ||
| Interleukin-10 regulates arterial pressure in early primate pregnancy | Q45225611 | ||
| Obesity predisposes to pregnancy toxemia (ketosis) of guinea pigs | Q46144979 | ||
| Peroxisome proliferator-activated receptor-γ as a potential therapeutic target in the treatment of preeclampsia | Q46327238 | ||
| Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers | Q46329980 | ||
| Mice overexpressing both human angiotensinogen and human renin as a model of superimposed preeclampsia on chronic hypertension | Q46332879 | ||
| Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. | Q46339760 | ||
| Discovery of a spontaneous genetic mouse model of preeclampsia | Q46351794 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts | Q47930364 | ||
| Magnesium for fetal neuroprotection | Q48281831 | ||
| Early platelet consumption in pre-eclampsia | Q50064171 | ||
| PLACENTAL PERMEABILITY IN A TOXEMIA-SUSCEPTIBLE STRAIN OF GUINEA PIGS. | Q50983926 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. | Q51139503 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. | Q51359651 | ||
| Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
| Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia | Q52995596 | ||
| Tumor necrosis factor α induces a model of preeclampsia in pregnant baboons (Papio hamadryas). | Q54360788 | ||
| Inhibition of Trophoblast-Induced Spiral Artery Remodeling Reduces Placental Perfusion in Rat Pregnancy | Q56981688 | ||
| Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening | Q56986820 | ||
| Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism | Q57500426 | ||
| Oxidative stress | Q59633631 | ||
| What every midwife should know about ACOG and VBAC. Critique of ACOG Practice Bulletin #5, July 1999, "Vaginal birth after previous cesarean section" | Q61843684 | ||
| Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units | Q61845775 | ||
| Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986 | Q64128968 | ||
| Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants | Q69685000 | ||
| Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries | Q70235106 | ||
| Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia | Q70897394 | ||
| Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen | Q71695937 | ||
| A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats | Q72059493 | ||
| Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia | Q72516832 | ||
| Expression of inflammatory cytokines in placentas from women with preeclampsia | Q73992120 | ||
| Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway | Q74477782 | ||
| Higher risk of pre-eclampsia after change of partner. An effect of longer interpregnancy intervals? | Q77070266 | ||
| Trophoblast deportation in human pregnancy--its relevance for pre-eclampsia | Q78144989 | ||
| Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia | Q80222982 | ||
| Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy | Q81369402 | ||
| Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia | Q82705098 | ||
| Reduced uterine perfusion pressure model is not successful to mimic severe preeclampsia | Q84489736 | ||
| ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists | Q95804650 | ||
| P433 | issue | 1 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| maternal health | Q6786626 | ||
| P304 | page(s) | 9-18 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Disease Models & Mechanisms | Q1524006 |
| P1476 | title | Preeclampsia: multiple approaches for a multifactorial disease | |
| P478 | volume | 5 |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q49842182 | A novel rodent model of pregnancy complications associated with genetically determined angiotensin converting enzyme (ACE) activity |
| Q37000033 | Apoptotic and stress signaling markers are augmented in preeclamptic placenta and umbilical cord |
| Q92680818 | Association of VEGFA and IL1β gene polymorphisms with preeclampsia in Sudanese women |
| Q37019976 | Association of Wnt2 and sFRP4 expression in the third trimester placenta in women with severe preeclampsia |
| Q36746936 | Biological rhythms and preeclampsia |
| Q34612601 | Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia |
| Q38124028 | Cell death mechanisms and potentially cytotoxic natural immune cells in human pregnancies complicated by preeclampsia |
| Q51315233 | Chemerin level in pregnancies complicated by preeclampsia and its relation with disease severity and neonatal outcomes. |
| Q36132172 | Comparative Study of Endothelial Function and Uterine Artery Doppler Velocimetry between Pregnant Women with or without Preeclampsia Development |
| Q37237709 | Comparison of extravillous trophoblast cells derived from human embryonic stem cells and from first trimester human placentas |
| Q50420199 | Cortical Responses to Chinese Phonemes in Preschoolers Predict Their Literacy Skills at School Age. |
| Q53773983 | Could mean platelet volume in late first trimester of pregnancy predict intrauterine growth restriction and pre-eclampsia? |
| Q50131577 | Current model systems for the study of preeclampsia. |
| Q90641335 | Decreased ALCAM expression and promoter hypermethylation is associated with preeclampsia |
| Q54996569 | Decreased IL-33 Production Contributes to Trophoblast Cell Dysfunction in Pregnancies with Preeclampsia. |
| Q50937133 | Decreased expression of WNT2 in villi of unexplained recurrent spontaneous abortion patients may cause trophoblast cell dysfunction via downregulated Wnt/β-catenin signaling pathway. |
| Q92277390 | Determining Whether Hypertensive Status and Stress Level Are Associated With Inflammatory Markers |
| Q53727721 | Difference of endothelial function during pregnancies as a method to predict preeclampsia. |
| Q36027832 | Differential Expression of Extracellular Matrix and Adhesion Molecules in Fetal-Origin Amniotic Epithelial Cells of Preeclamptic Pregnancy |
| Q93109012 | Disturbed Cardiorespiratory Adaptation in Preeclampsia: Return to Normal Stress Regulation Shortly after Delivery? |
| Q33842359 | Double hit of NEMO gene in preeclampsia |
| Q37379791 | Downregulated Krüppel-like factor 8 is involved in decreased trophoblast invasion under hypoxia-reoxygenation conditions |
| Q36578348 | Downregulation of Mitofusin 2 in Placenta Is Related to Preeclampsia |
| Q64253779 | Early onset preeclampsia in a model for human placental trophoblast |
| Q98290108 | Efficacy of Diltiazem for the Control of Blood Pressure in Puerperal Patients with Severe Preeclampsia: A Randomized, Single-Blind, Controlled Trial |
| Q36586387 | Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease |
| Q38707996 | Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor |
| Q34998392 | Evaluation of association of maternal IL-10 polymorphisms with risk of preeclampsia by A meta-analysis |
| Q53813091 | Evaluation of maternal serum progranulin levels in normotensive pregnancies, and pregnancies with early- and late-onset preeclampsia. |
| Q39768212 | Evidence Linking the Role of Placental Expressions of Peroxisome Proliferator-Activated Receptor-γ and Nuclear Factor-Kappa B in the Pathogenesis of Preeclampsia Associated With Periodontitis |
| Q33597631 | Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia |
| Q38918330 | Expression of DAB2IP in human trophoblast and its role in trophoblast invasion |
| Q97520323 | Functional Genomics of Healthy and Pathological Fetal Membranes |
| Q33654727 | Functional glycosylation in the human and mammalian uterus |
| Q37408068 | Genetic enhancement of microsomal epoxide hydrolase improves metabolic detoxification but impairs cerebral blood flow regulation. |
| Q34763454 | HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia |
| Q37385771 | High levels of HtrA4 observed in preeclamptic circulation drastically alter endothelial gene expression and induce inflammation in human umbilical vein endothelial cells |
| Q37420313 | Histomorphological and morphometrical changes of placental terminal villi of normotensive and preeclamptic mothers |
| Q64106954 | HtrA4 may play a major role in inhibiting endothelial repair in pregnancy complication preeclampsia |
| Q47550799 | Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father |
| Q36793344 | Immunomodulatory role of vitamin D in the pathogenesis of preeclampsia |
| Q38846766 | Immunostimulatory role of mitochondrial DAMPs: alarming for pre-eclampsia? |
| Q34419277 | Increased MPV is not a significant predictor for preeclampsia during pregnancy. |
| Q35628483 | Influence of preeclampsia and gestational obesity in maternal and newborn levels of vitamin D |
| Q44595585 | Influence of the AT(2) receptor on the L-arginine-nitric oxide pathway and effects of (-)-epicatechin on HUVECs from women with preeclampsia |
| Q34300423 | Interferon-γ protects first-trimester decidual cells against aberrant matrix metalloproteinases 1, 3, and 9 expression in preeclampsia |
| Q34927088 | Involvement of Galectin-9/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia |
| Q93125085 | Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy? |
| Q100761882 | Late first trimester circulating microparticle proteins predict the risk of preeclampsia < 35 weeks and suggest phenotypic differences among affected cases |
| Q35992280 | MSX2 Induces Trophoblast Invasion in Human Placenta |
| Q36606027 | Manifestations of immune tolerance in the human female reproductive tract |
| Q37051307 | Matrix metalloproteinase 9 is a distal-less 3 target-gene in placental trophoblast cells |
| Q39177295 | Methylenetetrahydrofolate reductase gene C677T, A1298C polymorphisms and pre-eclampsia risk: a meta-analysis |
| Q50933544 | Multiple Soluble TGF-β Receptors in Addition to Soluble Endoglin Are Elevated in Preeclamptic Serum and They Synergistically Inhibit TGF-β Signaling. |
| Q39283914 | New Models of Pregnancy-Associated Hypertension |
| Q26746049 | No Hypertensive Disorder of Pregnancy; No Preeclampsia-eclampsia; No Gestational Hypertension; No Hellp Syndrome. Vascular Disorder of Pregnancy Speaks for All |
| Q38945907 | Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis |
| Q48013934 | Oligomerization of FVFLM peptides and their ability to inhibit beta amyloid peptides aggregation: consideration as a possible model. |
| Q36848476 | Outcomes in hypertensive disorders of pregnancy in the North Indian population |
| Q52887370 | Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia. |
| Q89540684 | Placenta as a target of trichloroethylene toxicity |
| Q46754552 | Placental Hypoxia During Early Pregnancy Causes Maternal Hypertension and Placental Insufficiency in the Hypoxic Guinea Pig Model |
| Q50876184 | Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia. |
| Q37615825 | Pre-eclampsia and cardiovascular disease |
| Q33419126 | Pre-eclampsia has an adverse impact on maternal and fetal health |
| Q91728181 | Predicting peripartum blood transfusion: focusing on pre-pregnancy characteristics |
| Q35109763 | Prediction of early and late preeclampsia by flow-mediated dilation of the brachial artery |
| Q37296123 | Pregnancy enhances the effects of hypercholesterolemia on posterior cerebral arteries |
| Q33978151 | Pregnancy-related liver disorders |
| Q34317992 | Preterm birth and its long-term effects: methylation to mechanisms |
| Q38691672 | Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy |
| Q43857052 | Promoter Methylation Status of WNT2 in Placenta from Patients with Preeclampsia |
| Q47588982 | Promotion of trophoblast invasion by lncRNA MVIH through inducing Jun-B. |
| Q39144666 | RNA interference-mediated silencing of laminin receptor 1 (LR1) suppresses migration and invasion and down-regulates matrix metalloproteinase (MMP)-2 and MMP-9 in trophoblast cells: implication in the pathogenesis of preeclampsia |
| Q64279160 | Resveratrol promotes trophoblast invasion in pre-eclampsia by inducing epithelial-mesenchymal transition |
| Q37565739 | Serum levels of tumor necrosis factor-α, interleukin-15 and interleukin-10 in patients with pre-eclampsia in comparison with normotensive pregnant women |
| Q37219833 | Snoring during pregnancy and delivery outcomes: a cohort study |
| Q90090385 | Status of VEGF in preeclampsia and its effect on endoplasmic reticulum stress in placental trophoblast cells |
| Q91902879 | Syndecan-4 regulates extravillous trophoblast migration by coordinating protein kinase C activation |
| Q36104833 | Systematic Review of Micro-RNA Expression in Pre-Eclampsia Identifies a Number of Common Pathways Associated with the Disease |
| Q37419194 | The Lnc RNA SPRY4-IT1 Modulates Trophoblast Cell Invasion and Migration by Affecting the Epithelial-Mesenchymal Transition |
| Q37502706 | The complement cascade and renal disease. |
| Q42778089 | The lncRNA TUG1 modulates proliferation in trophoblast cells via epigenetic suppression of RND3. |
| Q38095221 | The placenta in toxicology. Part I: Animal models in toxicology: placental morphology and tolerance molecules in the cynomolgus monkey (Macaca fascicularis). |
| Q37586041 | The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisited |
| Q33598128 | Transthyretin regulates the migration and invasion of JEG-3 cells |
| Q50054365 | Trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine induces lipid peroxidation-associated apoptosis via the intrinsic and extrinsic apoptosis pathways in a first-trimester placental cell line |
| Q34481622 | Trophoblast expression of the minor histocompatibility antigen HA-1 is regulated by oxygen and is increased in placentas from preeclamptic women |
| Q47141754 | Vascular corrosion casting of normal and pre-eclamptic placentas |
| Q36119044 | Why is placentation abnormal in preeclampsia? |
| Q46696961 | With adaptation, the WHO guidelines on calcium supplementation for prevention of pre-eclampsia are adopted by pregnant women |
| Q35062407 | sFLT1 in preeclampsia: trophoblast defense against a decidual VEGFA barrage? |
Search more.